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Introduction
Hydration status and its role in the performance of endurance 
athletes remains a popular topic of debate in sports medicine. Newer 
recommendations, including the 2007 American College of Sports 
Medicine Position Stand on Exercise and Fluid Replacement, warn 
athletes not to lose >2% body weight during exercise as it may adversely 
affect performance.1 Although the same paper recommends drinking 
to thirst, the unfounded fear of dehydration and/or heat illness may 
have prompted athletes in the USA to continue to follow protocols 
that promote overzealous hydration. However, more recent analysis 
has shown that the fastest runners (therefore highest performers) 
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was to determine if slower pace is associated with increased 
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(p<0.001). The prevalence of post-race hyponatraemia was 
4% (4/106) among half-marathoners and 13% (12/89) among 
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had a significantly higher prevalence of hyponatraemia. The 
development of hyponatraemia was associated with weight 
gain. Our data indicate that the relationship between post-race 
sodium concentration and pace differs according to the distance 
of the event. We can extrapolate from this data that longer race 
distance with increased availability of fluid stations combined 
with a slower pace may increase the risk of developing exercise-
induced hyponatraemia.
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actually are those who lose the most weight in marathons.2 The 
recognition of the potential dangers of excessive fluid consumption 
has initiated multiple revisions of these theories. Current hydration 
strategies may be based on individual sweat rate, as monitored by 
body weight change during exercise, but most importantly should be 
gauged by thirst to maximise performance.1,3-7  
Many studies and review papers have documented the risk of 
overhydration during prolonged endurance events, which may 
result in hyponatraemia (serum sodium concentration <135 
mmol/l).1,5,8-21 The occurrence of hyponatraemia during or up to 
24 hours after prolonged physical activity is known as exercise-
associated hyponatraemia (EAH).8,12 A large study from Noakes et 
al. reveals that the development of EAH occurs from three main 
factors: overconsumption of fluid during exercise, retention of fluid 
due to inadequate suppression of antidiuretic hormone (ADH), and 
inactivation of or failure to reactivate internal stores of sodium.22 
The confluence of these factors enhances a dilutional state and 
decreases the serum sodium concentration. Signs and symptoms of 
hyponatraemia include nausea, vomiting, confusion, and headache. 
As EAH progresses, more severe sequelae include seizures, pulmonary 
and cerebral oedema (hyponatraemic encephalophathy), and possibly 
death. Since its first report in a 26.2 mile (42 km) race in the 1986 
Pittsburgh Marathon, EAH has been cited in multiple hospitalisations 
and at least 5 known deaths of marathon participants.9,18,19 Developing 
science and recognition of EAH have linked multiple risk factors, 
including excessive drinking behaviours, female sex, failure to 
appropriately suppress ADH in the presence of fluid retention, lower 
body mass index (BMI), slower running pace, non-elite status, and 
prolonged exercise (>4 hours).1,9,10,12-14,20
Our primary aim was to determine if slower pace is associated with 
increased prevalence of hyponatraemia. A secondary aim was to determine 
if there is a significant difference in the prevalence of hyponatraemia 
in half- v. full-marathon participants. This study has the advantage of 
analysing both pre- and post-race serum sodium concentrations, as 
well as the weight of participants before and after exercise to assess the 
changes incurred during an endurance event. Furthermore, we believe 
the current study is the first to examine the influence of race pace on 
the prevalence of hyponatraemia with the benefit of data from both 
half- and full-marathons. With these data, we propose that EAH is, in 
part, a behavioural disease in which athletes are influenced by tenuous 
information, the availability of fluid stations, and fear of dehydration.
Methods
Subjects
This observational, cross-sectional study comprised consenting 
runners who participated in the first 26.2 With Donna, The National 
Marathon to Finish Breast Cancer Full and Half Marathons. Study 
design was approved by the Institutional Review Board and used 
written informed consent and a Health Insurance Portability and 
Accountability Act waiver. Race participants were approached at 
random during the Health Expo held on the 2 days before the race. 
Consenting subjects, at least 18 years of age, were identified by a 
brightly coloured sticker on their race bib number.
Race setting
The race took place on 17 February 2008 at Jacksonville Beach, 
Florida. At the start of the race, 08h30, the ambient temperature was 
17.8°C (64°F) and humidity 88%. Sunny conditions prevailed at the 
end of the race, with an ambient temperature of 24.4°C (76°F) and 
43% humidity. Hydration stations were available approximately every 
mile, with a sports drink (Powerade; Coca-Cola Company, Atlanta, 
Georgia) offered at every other station. A carbohydrate energy gel (GU 
Energy Gel; GU Energy Labs, Berkeley, California) was also available 
roughly every 3 - 5 miles after mile marker 10.  Runners were provided 
race bags that had various advertisements, race paraphernalia, and 
local health magazines (www.HealthSourceMag.com). No specific 
instructions regarding hydration were given to race participants. 
Procedures
Serum sodium concentration was measured the morning of the 
race and after race completion. Height was self-reported by the 
participants. Weight was measured on the same calibrated scale before 
and after the race. BMI (weight in kilograms divided by the square of 
height in metres) was calculated before and after the race. Runners 
were instructed to proceed to the Runners’ Science research tent on 
completion of the race. They were allowed to consume fluid freely after 
the race while waiting for their blood to be drawn. Venous blood was 
collected via finger stick and tested on a tabletop analyser (Stat Profile 
Critical Care Xpress; Nova Biomedical, Waltham, Massachusetts). 
Before the marathon, set-up and implementation studies for linearity 
and precision were performed by the vendor to meet industry 
standards. In an effort to maintain impartial interpretation, the results 
were not reviewed at the time. Therefore, no opportunity existed to 
recommend for or against participation in the race on the basis of 
pre-race laboratory values.
Outcome measures
The primary outcome measure was the incidence of hyponatraemia 
(serum sodium concentration [Na+] <135 mmol/l). Secondary outcome 
measures included mean changes observed and determination of any 
statistically significant changes in paired data sets from before and 
after the race. Completion times were recorded by official chip time. 
Race pace, reported in minutes per mile, was calculated by finish time 
divided by race distance (13.1 or 26.2 miles). 
Sample size considerations
The target enrolment was 250 runners, based on an expected 
volunteer rate of 5% of the  5 000 race participants. After allowing for 
the loss of up to 20% of records due to inadequate blood samples, we 
estimated that the prevalence of electrolyte abnormalities would be 
estimable to within a 3 - 7% margin of error, depending on the true 
prevalence and assuming the use of a large-sample approximation 
to the 95% confidence interval. Therefore, the target sample size was 
expected to provide reasonable precision in the estimation of the 
pre- and post-race prevalence of electrolyte abnormalities.
Analysis
Continuous variables were summarised using median and range, and 
categorical variables were summarised using number and percentage. 
To evaluate the relationship between categorical variables, such 
as marathon distance (full v. half) and hyponatraemia status, we 
used the Fisher exact test. The Wilcoxon rank sum test was used 
to compare continuous measures, including race pace and change 
in serum sodium levels, between full- and half-marathoners. The 
Spearman correlation coefficient was used to assess the correlation 
between race pace or finishing time and other continuous variables. 
Linear regression was used to explore the relationship between post-
race serum sodium level, race pace, and distance.
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Ethical considerations
Restriction of participation based on pre-race laboratory data was not 
possible because of the blood analysis processing method. Pre-race 
samples were stored on ice and transported to the laboratory at the 
main campus. Laboratory results were not available until after the race. 
If a symptomatic research participant presented to the race medical 
tent for treatment, laboratory values were available immediately for 
use by the treating physician. Study investigators were notified and 
collected a separate blood sample of research participants presenting 
to the medical tent.
Results
Total enrolment of 251 was completed early on the second day of 
the Health Expo. Although the target enrolment was met without 
difficulty, 18% (46/251) and 19% (47/251) of enrolled runners did not 
present for pre-race and post-race finger-stick sampling, respectively. 
Additional records were lost during the process of laboratory analysis. 
See Fig. 1 for data flow illustration. 
A total of 161 and 195 records remained for pre-race and post-
race analyses, respectively. The 39 pre-race records lost because the 
quantity of blood was insufficient were deemed likely secondary to 
chilly morning conditions and associated peripheral vasospasm. 
Notably, the number of post-race analyses with insufficient blood 
quantity was substantially lower at 7 records, presumably because 
blood samples were easier to obtain in the warmer digits of runners 
who just completed the race. There were slightly more half-marathon 
participants than full-marathon participants in both the pre- and 
post-race environments. Approximately equal numbers of pairs, 
however, were available for paired analysis (79 half-marathon v. 70 
full-marathon pairs).
Table 1 summarises characteristics of the subjects, according to 
full- or half-marathon status. There was no statistical difference in age 
or sex by race type. Notably, there was a strong female participation 
rate of 71% (178/251). The overall race participants were similarly 
skewed toward a higher female component of 71% (3 950/5 536). 
Table 1 also includes the median changes observed in serum sodium 
levels between the pre-race and post-race environments. Interestingly, 
more half-marathoners (5/84 (6.0%)) than full-marathoners (3/77 
Table 1. Characteristics of the Runners’ Science Study Participants according to full- or half-marathon status*
Characteristic All participants Full-marathoners Half-marathoners p-value
Sex (male) 73/251 (29) 40/125 (32) 33/126 (26) 0.33
Age (years) 46 (20 - 71) 46 (20 - 70) 45 (24 - 71) 0.73
Finish time (min) 240 (90.6 - 398.7) 333.7 (194.4 - 398.7) 166.1 (90.6 - 358.6) <0.001
Pace (min/mile) 12.7 (6.9 - 27.4) 12.7 (7.4 - 15.2) 12.7 (6.9 - 27.4) 0.47
Fluid ingested (cups) 16 (1.5 - 100) 27.5 (2 - 100) 12.0 (1.5 - 64.0) <0.001
Fluid ingested (cups/min) 0.08 (0.008 - 0.34) 0.08 (0.008 - 0.34) 0.08 (0.01 - 0.33) 0.29
Hyponatraemia
Pre-race 8/161 (5) 3/77 (4) 5/84 (6) 0.72
Post-race 16/195 (8) 12/89 (13) 4/106 (4) 0.02
Sodium concentration (mmol/l)
Pre-race 138.7 (105.4 - 145.8) 139 (133.2 - 145.8) 138 (105.4 - 143) 0.16
Post-race 140 (125 - 157) 140 (125 - 157) 140 (125 - 151) 0.07
Change (post-pre) 2.0 (-11.0 - 35.6) 0.5 (-11.0 - 16.0) 2.0 (-6.7 - 35.6) 0.03
Body mass index, median (range), kg/m2
Pre-race 24.5 (18.1 - 42.2) 24.0 (18.2 - 33.2) 25.0 (18.1 - 42.2) 0.32
Post-race 24.0 (17.7 - 36.7) 23.6 (17.7 - 32.6) 24.5 (18.1 - 36.7) 0.28
Change (post-pre) -0.4 (-1.8 - 0.5) -0.6 (-1.8 - 0.2) -0.3 (-0.8 - 0.5) <0.001
Weight, median (range), kg
Pre-race 68.5 (43.1 - 120.1) 67.9 (43.1 - 111.1) 68.6 (50.5 - 120.1) 0.69
Post-race 67.1 (41.0 - 117.5) 67.0 (41.0 - 108.3) 67.3 (50.1 - 117.5) 0.60
Change (post-pre) -1.1 (-5.7 - 1.4) -1.5 (-5.7 - 0.7) -0.8 (-2.7 - 1.4) <0.001
*Continuous variables are reported as median (range), with comparisons between full- and half-marathoners performed using the Wilcoxon rank sum test. Categorical variables are reported as fraction 
(percentage), with comparisons between full- and half-marathoners performed using the Fisher exact test.
Fig. 1. Data flow in pre- and post-race settings in accordance with 
race distance.
SAJSM  VOL 24  NO. 2  2012 39
(3.9%)) presented with hyponatraemia before the race, with 1 
asymptomatic half-marathoner in a state of laboratory-classified 
severe hyponatraemia (serum sodium 105 mmol/l). However, this 
difference was not statistically significant (p=0.72). At completion 
of the race, 3 times as many full-marathoners as half-marathoners 
were hyponatraemic (12/89 (13.5%) and 4/106 (3.8%), respectively; 
p=0.02). There was a significant difference in the change in sodium 
levels between half- and full-marathon runners. The median increase 
was 2.0 mmol/l for half-marathon runners (range, -6.7 - 35.6 mmol/l) 
and 0.5 mmol/l for full-marathon runners (range, -11.0 - 16.0 mmol/l) 
(p=0.03, Wilcoxon rank sum test). Therefore, full-marathon runners 
experienced a smaller increase in sodium over the course of the race, 
and significantly more full-marathoners than half-marathoners were 
hyponatremic after the race (p=0.02). 
Data of the change in weight (kg) and calculated in BMI (kg/m2) 
among runners indicated that full-marathoners lost significantly 
more weight during the race (-1.5 kg, -0.6 kg/m2) than half-
marathoners (-0.8 kg, -0.3 kg/m2) (p<0.001, p<0.001).  An inverse 
correlation was found between sodium change and weight change, 
significant in full-marathoners (Spearman correlation r=-0.55, 
p<0.001) but not half-marathoners (r=-0.23, p=0.042) (Fig. 2). 
See Table 2 for full data on hyponatraemic participants according 
to change in pre- and post-race sodium concentration (mmol/l) 
and weight (kg). Of the 16 participants who were hyponatraemic 
post-race, 6 showed an increase in weight. The mean weight 
change for the hyponatraemic marathoners was -0.07 kg2 (range, 
-0.9 - 1.4 kg).
The median race pace was 12.7 min/mile (range, 6.9 - 27.4 min/
mile) for half-marathoners and 12.7 min/mile (range, 7.4 - 15.2 min/
mile) for full-marathoners. A significant negative association was 
found between pace and post-race serum [Na+] (Spearman correlation 
r=-0.30, p<0.001) (Fig. 3). Median finishing times for half- and full-
marathoners were 166.1 minutes (range, 90.6 - 358.6 minutes) and 
333.7 minutes (range, 194.4 - 398.7 minutes), respectively. Finishing 
Table 2. Reporting pre- and post-race hyponatraemic participants according to change in sodium concentration (mmol/l) and weight 

























A Half *   134.0 Yes * 67.6 67.6 0
B Half 141.0 No 134.3 Yes -6.7 61.8 63.2 1.4
C Half 139.8 No 134.0 Yes -5.8 62.7 63.5 0.8
D Full 139.0 No 133.0 Yes -6.0 60.3 59.4 -0.9
E Full 139.0 No 132.0 Yes -7.0 64.5 63.8 -0.7
F Full 142.0 No 133.0 Yes -9.0 91.5 92.0 0.5
G Full 136.0 No 130.0 Yes -6.0 53.7 53.8 0.1
H Full 139.0 No 133.0 Yes -6.0 61.5 60.7 -0.8
I Full 138.0 No 132.0 Yes -6.0 96.5 95.7 -0.8
J Full 136.0 No 131.0 Yes -5.0 65.9 66.6 0.7
K Full 136.1 No 133.0 Yes -3.1 49.2 49.0 -0.2
L Full 136.0 No 125.0 Yes -11.0 54.2 54.6 0.4
M Full 138.0 No 133.0 Yes -5.0 83.4 82.6 -0.8
N Full 141.9 No 134.0 Yes -7.9 65.3 65.1 -0.2
O Half 130.7 Yes 125.0 Yes -5.7 75.5 *  
P Full 134.0 Yes 133.0 Yes -1.0 84.2 83.6 -0.6
Q Half 134.0 Yes 136.0 No 2.0 75.3 75.3 0
R Half 105.4 Yes 141.0 No 35.6 54.2 53.1 -1.1
S Half 134.7 Yes 138.0 No 3.3 76.5 77.2 0.7
T Half 1330 Yes 135.0 No 2.0 51.5 51.7 0.2
U Full 134.0 Yes 137.0 No 3.0 64.6 62.9 -1.7
V Full 133.2 Yes 142.0 No 8.8 50.2 49.7 -0.5
Fig. 2. Scatterplots of the change in weight (kg) v. change in serum 
sodium concentration (mmol/l) from post- to pre-race in (A) full- 
and (B) half-marathon participants.
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time and post-race sodium level had a significant negative correlation 
as well (Spearman correlation r=-0.28, p=0.001). 
Discussion
This study is the first of which we are aware to examine the influence 
of race pace on the prevalence of hyponatraemia with the benefit of 
data from both half- and full-marathons. Prior studies have shown 
an increased incidence of hyponatraemia in marathon runners with 
completion times of more than 4 hours.8,11-13,17,21 No studies found in a 
review of the literature have looked at actual race pace as a predictor of 
hyponatraemia. The consensus statement from the Second International 
Exercise-Associated Hyponatraemia Consensus Development 
Conference 2007 named slower running or performance pace to its 
list of athlete-related risk factors.12 However, of the 4 articles cited after 
this statement,8,11,17,21 only Almond et al.,8 reporting data from the 2002 
Boston Marathon, commented on pace; the others focused on longer 
finishing times, generally more than 4 hours. Furthermore, Almond 
et al.8 reported only a slower training pace as statistically significant 
(self-reported by runners on pre-race surveys), but did not calculate 
pace on the actual day of the race. As EAH is nearly non-existent in 
some countries, such as South Africa and New Zealand, our data also 
implicate the perpetuation of fear of dehydration that may continue to 
promote overconsumption of fluids in the USA.
Hew et al.17 reported that longer finishing times and 
overconsumption of fluids were the main risk factors associated with 
the development of hyponatraemia. Specifically, they state finishing 
times of more than 4 hours 20 minutes resulted in the lowest serum 
sodium levels. Although a slower pace can be inferred from this 
statement, with only a 26.2 mile marathon on which to base their 
calculations, they were not able to consider distance in relation to 
change in sodium.
Current global data have established a prevalence of pre-race 
hyponatraemia of 0 - 2%.23 Our results demonstrate a pre-race 
incidence of 6.0% (5/84) for half-marathoners and 3.9% (3/77) for full-
marathoners. Higher pre-race incidence of hyponatraemia in the USA 
raises the question of race participant education. Race packets were 
picked up at the expo 1 - 2 days prior to the race. Among advertisement 
of sponsors, HealthSource Magazine (HealthSourceMag.com) was 
included, which may have included advice from local nutritionists. 
For example, the February 2010 edition contained an article entitled ‘A 
runner’s diet’. Recommendations included: ‘To avoid hitting the wall 
... you need to focus on your diet and hydration many days before the 
event. Be sure to increase intake of all fluids and be in a well hydrated 
state. Dehydration adversely affects athletic performance.’24  These 
messages may have encouraged runners to overhydrate prior to the 
race.  The post-race hyponatraemia prevalence of 13% (12/89) in 
full-marathoners is in agreement with cohorts evaluated in Boston 
(13%)8 and London (12%).23 In contrast, EAH has yet to be reported 
in a marathon runner in South Africa or New Zealand, and only 
occasional cases occur in longer ultramarathon races in South Africa 
(T D Noakes, personal communication).
Our data support the prior finding that a significant inverse 
relationship exists between total finishing time and serum [Na+] 
(p<0.001). Additionally, with the benefit of data from two different 
distances, we were able to demonstrate the importance of the pace-
distance interaction with change in sodium. In Fig. 4, a linear 
regression model of post-race sodium with pace, distance, and the 
pace-distance interaction as independent variables found a significant 
interaction between pace and distance (p=0.03). As interactions are 
difficult to detect, this model indicates that the relationship between 
post-race sodium and pace indeed differs according to the distance 
of the run.
Davis et al.11 reported a retrospective analysis of marathon 
participants in the 1998 and 1999 Suzuki Rock ’N’ Roll Marathon 
in San Diego, California, who presented within 24 hours after the 
conclusion of the race to a local emergency department. To define 
unconditioned v. conditioned athletes, the patients were stratified 
into those finishing in more or less than 4 hours, respectively. None 
of the hyponatraemic patients finished the race in less than 4 hours, 
suggesting that unconditioned athletes, or those who run slowly, are 
at risk for the development of EAH. Davis et al.11 also discussed the 
impact of post-race hyperhydration as a major contributor to the 
development of EAH. A possible limitation to our study design is 
that post-race blood samples were collected directly after the race; 
therefore, we only measured a minimum occurrence and may have 
missed the development of EAH in those participants who then 
continued to hydrate aggressively over the next 24 hours.
Both Hew et al.17 and Davis et al.11 commented on the inverse 
relationship of serum sodium to time of presentation. These data 
were retrospectively reviewed from medical tents and emergency 
department visits. Our study was geared specifically to screen for 
abnormal serum sodium concentrations that developed during the 
Fig. 3. Scatterplots of post-race serum sodium levels v. race pace for 
full-marathoners and half-marathoners.
Fig. 4. Scatterplot of the inverse relationship between post-race 
serum sodium level and race pace, with overlaid linear regression 
lines for full- and half-marathoners (p=0.03). 
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endurance race. Recruited participants were instructed to present to 
the Runners’ Science tent before and after the race. Consequently, we 
were unable to report on time of presentation in relation to serum 
sodium except with regard to race finish time. Of note, 360 ml (12 
oz) water bottles were available at the finish line, and race participants 
could drink at will while waiting to have blood drawn. Therefore, it 
is plausible to assume that out of fear of dehydration, those who used 
the ‘drink as much as possible’ philosophy may have continued to 
overhydrate after the race and thus have had lower serum sodium 
levels than if they had hydrated to thirst.
Our study is in agreement with the Consensus Statement on EAH12 
that weight gain during a race is a risk factor for hyponatraemia. Of 
the 16 participants who were hyponatraemic after the race, 6 showed 
an increase in BMI with a mean change of 0 kg/m2 (range, -0.3 - 0.5 
kg/m2). Although more full-marathoners developed hyponatraemia 
during the race, full-marathoners also lost significantly more weight 
than their counterparts in the half-marathon. This can be explained by 
a possible 1 - 2% decrease in body weight that can occur during a 26.2 
mile marathon without a change in total body water. This scenario may 
lead to a dilutional hyponatraemic state with a net loss or neutral BMI.
Our results also show that, despite an equal median pace of 
12.7 min/mile in both half- and full-marathoners, the latter had a 
significantly higher prevalence of hyponatraemia (p=0.02). This 
finding further supports the importance of the performance pace-
distance interaction. It may be proposed that a difference between 
the half- and full-marathon race courses is the number of hydration 
stations. Along our race course, the availability of hydration stations 
at each mile marker essentially doubled in the full- v. half-marathon. 
Reid et al.25 reported that the limitation of fluid availability with 
placement of aid stations every 5 km has been shown to be associated 
with absence of hyponatraemia in a standard marathon. We plan to 
recommend this arrangement of fluid stations for future races.
Our study design is not without its limitations. First, selection bias 
may have occurred with race participants who are more interested 
in health outcomes associated with endurance racing. Second, both 
data sets were incomplete, limiting paired data set analysis. Also, as 
mentioned above, by collecting blood directly after the race, we lost 
the ability to detect development of hyponatraemia in the subsequent 
24 hours.  Finally, our study, as well as race participants overall, 
may have some gender bias toward a higher female component, 
71% (178/251) compared with 34.4% female finishers reported by 
Hew et al.17 This may be attributable to the nature of the race to 
benefit breast cancer research and women living with breast cancer. 
Given that the consensus statement on EAH12 names female sex as 
a risk factor, our study population may have been predisposed to 
development of EAH.  Finally, we acknowledge the role of certain 
confounding factors on the data. Although our figures clearly 
suggest that slower pace increases the risk of hyponatraemia, we 
are unable to determine if this is a true physiological difference due 
to pace. Rather, it may be due to the impact of outside influence of 
education favouring excessive hydration out of fear of dehydration. 
Or perhaps, when moving at a slower pace, athletes simply have 
more time to drink at fluid stations. 
In summary, recommendations on fluid replacement during 
endurance races continue to evolve. Currently at the forefront is 
drinking ad libitum (according to thirst) with the goal to replace 
fluid lost as sweat. Runners should be encouraged to individualise 
their hydration strategy on the basis of their particular sweat rates 
to optimise rather than maximise fluid intake during running.11 
It is imperative that the sports medicine community promote 
this strategy rather than continue to uphold the unsubstantiated 
fear of dehydration.  Hyponatraemia occurred significantly more 
frequently in full-marathoners than in half-marathoners. With the 
benefit of data from half- and full-marathons, we have illustrated 
the intricate relationship among race pace, distance, and serum 
sodium concentration.  If EAH truly is a behavioural disease based in 
overconsumption of fluids, then appropriate education and behaviour 
modification is the key for prevention.
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